Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

PURPOSE: Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving chemotherapy. The objective of this study was to define, from the UK payer perspective, the cost-effectiveness of an antiemetic regimen using aprepitant, a selective neurokinin-1 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphreys, Samantha, Pellissier, James, Jones, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742066/
https://www.ncbi.nlm.nih.gov/pubmed/23950658
http://dx.doi.org/10.2147/CMAR.S44539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742066/
https://www.ncbi.nlm.nih.gov/pubmed/23950658
http://dx.doi.org/10.2147/CMAR.S44539

Ejemplares similares